Type(s) of Cancer
Leukemia/Lymphoma
Leukemia/Lymphoma
Study Phase
Phase 2B
Study Completion Date
2008-10
2008-10
NCT00301821Uploaded 08-28-2017
Available for Download
PDS UID: Lymphom_Allianc_2006_212
A Phase II Study of Epratuzumab, Rituximab (ER)-CHOP for Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
Files:![](/projectdatasphere/Images/icons/icon-pdf.png)
![](/projectdatasphere/Images/icons/icon-pdf.png)
![](/projectdatasphere/Images/icons/icon-docx.png)
![](/projectdatasphere/Images/icons/icon-sas7bdat.png)
![](/projectdatasphere/Images/icons/icon-sas7bdat.png)
![](/projectdatasphere/Images/icons/icon-pdf.png)
PROTOCOLN0489Prot_06Aug2008.pdf
![](/projectdatasphere/Images/icons/icon-pdf.png)
CRFFormsPacket_21Sep2007.pdf
![](/projectdatasphere/Images/icons/icon-docx.png)
DATA DICTIONARYn0489_datasphere_datadictionary.docx
![](/projectdatasphere/Images/icons/icon-sas7bdat.png)
DATA (ACTIVE ARM)outcome17mar24.sas7bdat
![](/projectdatasphere/Images/icons/icon-sas7bdat.png)
DATA (ACTIVE ARM)events.sas7bdat